NOT:ETR
Novartis AG
€ 128.48
arrow_upward
+0.11%(+0.14) Siku 1
29 Sep, 11:39:18 GMT +2 · EUR
search
Alama zote
Siku 1
Siku 5
Mwezi 1
Miezi 6
YTD
Mwaka 1
Miaka 5
ISIZIDI
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NOT...
Fungua
€ 128.60
Juu
€ 128.92
Chini
€ 128.20
Mtaji wa soko
247.52B
Wastani wa kiasi cha mauzo
elfu 5.96
Kiasi cha mauzo ya hisa
elfu 1.17
Juu kwa wiki 52
€ 144.12
Chini kwa wiki 52
€ 104.52
Idadi ya wafanyakazi
elfu 75
Fungua
€ 128.60
Juu
€ 128.92
Chini
€ 128.20
Mtaji wa soko
247.52B
Wastani wa kiasi cha mauzo
elfu 5.96
Kiasi cha mauzo ya hisa
elfu 1.17
Juu kwa wiki 52
€ 144.12
Chini kwa wiki 52
€ 104.52
Idadi ya wafanyakazi
elfu 75
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
BioSpace
·
saa 4 zilizopita
3 steps for taking on Novartis in radiopharma: Curium up first
Yahoo Finance
·
saa 11 zilizopita
Novartis (NVS) Has More Growth Ahead. Can its Portfolio Outrun Generic Pressure?
AD HOC NEWS
·
saa 14 zilizopita
Novartis stock at CHF 121.22 on September 28, 2026
AD HOC NEWS
·
siku 1 iliyopita
Novartis stock gets a higher FY2027 EPS forecast
Wasifu
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Kuhusu Novartis AG
Afisa Mkuu Mtendaji (CEO)Vasant Narasimhan
Wafanyakazielfu 75.3
Lilianzishwa7 Mac 1996
Makao makuuBasel, Mji wa Basel, Uswisi
Sekta-
Tovutinovartis.com